ABSTRACT 2-hydroxyglutarate (2-HG) is a hypoxic metabolite with potentially important epigenetic signaling roles. The mechanisms underlying 2-HG generation are poorly understood, but evidence suggests a potential regulatory role for the sirtuin family of lysine deacetylases. Thus, we hypothesized that the acetylation status of the major 2-HGgenerating enzymes (isocitrate dehydrogenase (IDH), malate dehydrogenase (MDH) and lactate dehydrogenase (LDH)) may govern their 2-HG generating activity. In-vitro acetylation of these enzymes, with confirmation by western blotting, mass spectrometry, and reversibility by incubation with recombinant sirtuins, yielded no effect on 2-HG generating activity. In addition, while elevated 2-HG in hypoxia is associated with the activation of lysine deacetylases, we found that mice lacking mitochondrial SIRT3 exhibited hyperacetylation and elevated 2-HG. These data suggest there is no direct link between enzyme acetylation and 2-HG production. Furthermore, our observed effects of in-vitro acetylation on the canonical activities of IDH, MDH and LDH appeared to contrast sharply with previous findings wherein acetyl-mimetic lysine mutations resulted in inhibition of these enzymes. Overall these data suggest that a causal relationship should not be assumed, between acetylation of metabolic enzymes and their activities, canonical or otherwise.
INTRODUCTION

2-hydroxyglutarate (2-HG) is a non-canonical metabolite with potential signaling
roles that is synthesized from the Krebs cycle metabolite α -ketoglutarate (α-KG). Among the enzymes thought to convert α -KG to 2-HG are cancer-linked forms of mitochondrial NADP + -dependent isocitrate dehydrogenase (IDH2) [1] , as well as malate dehydrogenase type 2 (MDH2) [2] and lactate dehydrogenase (LDH) [3, 4] . The mechanisms which trigger a neomorphic 2-HG synthetic activity are not fully elucidated.
It has been reported that a specific IDH2 mutation (R 172 K) found in glioma cells facilitates 2-HG production [1] , leading to the early characterization of 2-HG as an oncometabolite. In addition, hypoxia [3] [4] [5] and acidic pH [6] [7] [8] trigger 2-HG production by MDH2 and LDH. Acidic pH is thought to protonate α -KG, enhancing its access to the substrate binding pocket of these enzymes [7] . However, it is unclear whether posttranslational modification of these enzymes can also regulate 2-HG production.
Lysine acetylation, regulated by the sirtuin family of NAD + -dependent protein deacylases (SIRTs) [9] , is emerging as an important regulatory mechanism for numerous metabolic processes [10] [11] [12] [13] . Previously we demonstrated that an elevation in 2-HG levels observed in cardiac ischemic preconditioning (IPC) was associated with lysine deacetylation [14, 15] , and we and others showed that IPC-induced deacetylation occurs on IDH2, MDH2 and LDH-A [15] [16] [17] . Intriguingly, both lysine deacetylation and the elevation in 2-HG seen in IPC were inhibited by the SIRT1 inhibitor splitomicin (Sp) [14, 15] . As such, we hypothesized herein that the 2-HG generating capacity of these dehydrogenases may be regulated by lysine acetylation status.
.
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METHODS
Reagents
All chemicals and reagents were obtained from Sigma (St. Louis MO) unless otherwise stated. LDH was from bovine heart (L3916, Sigma), while MDH2 (M2634, Sigma) and NADP + dependent mitochondrial IDH2 (I2002, Sigma) were from porcine heart. HEK293 cells were from ATCC (Manassas VA).
In-vitro protein acetylation & western blotting
Protein acetylation was performed similar to [18] . IDH2, MDH2 or LDH (2 mg/ml)
were incubated overnight at 37 ºC in 50 mM Tris-HCl (pH 8) plus 1.5 mM acetyl coenzyme A, followed by neutralization of pH prior to further analysis. For MDH2, acetylated protein was further subjected to deacetylation by incubation with recombinant human SIRT3 (ab125810, AbCam, Cambridge MA).
To monitor protein acetylation, naïve and acetylated proteins were resolved on 12% SDS-PAGE gels, transferred to nitrocellulose and probed with pan anti-acetyl-lysine (K-Ac) or anti-SIRT3 antibodies (Cell Signaling, Danvers MA) at 1:1000 dilution, followed by HRPlinked secondary antibody (GE Biosciences, Pittsburgh PA) at 1:2500 and enhanced chemiluminescent detection (Pierce, Rockford IL). In addition for MDH2, acetylation at the previously published K 239 site [17, 19] was determined by mass spectrometry (Thermo Scientific Q-Exactive) in the University of Rochester Proteomics and Mass Spectrometry Core Facility. In brief, proteins were reduced and alkylated (DTT, IAA), trypsinized (Pierce) desalted (C18 Tips, Pierce), dried and suspended in 0.1% TFA. Peptides were separated by C18 HPLC (Easy nLC-1000, Thermo Fisher), with a custom column and an elution gradient of 0.1% formic acid in water 0.1% formic acid in acetonitrile over 30 min. LC effluent was diverted to a Q Exactive Plus mass spectrometer (Thermo Fisher), operated . CC-BY-NC 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/141416 doi: bioRxiv preprint first posted online  in data-dependent mode, with a full MS1 scan (400-1400 m/z, resolution 70,000 at m/z 200, AGC target of 10 6 , max injection time 50 ms), followed by 8 data-dependent MS2 scans (resolution 35,000, AGC target of 10 5 , max injection time 120 ms). Isolation width was 1.5 m/z, offset 0.3 m/z, and normalized collision energy 27. Raw data were searched using Mascot (Matrix Science) within Proteome Discoverer software (Thermo Fisher), using the SwissProt Sus scrofa database with <2 missed cleavages, MS1 tolerance 10 ppm, and MS2 tolerance 25 mmu. Carbamidomethyl was set as a fixed modification, with methionine oxidation, lysine acetylation and N-term acetylation as variable modifications.
Percolator was used as the FDR calculator, filtering peptides with q-value > 0.01.
Enzyme activities and LC-MS/MS metabolite assays
Activities of IDH, MDH or LDH were measured spectrophotometrically at 340 nm, representing either the consumption of NADH (for MDH2 and LDH) or the generation of NADPH (for IDH2) [6] . In addition, aliquots from spectrophotometric cuvets were withdrawn for quantitation of selected reaction substrates or products by LC-MS/MS as previously reported [6] . Note: The LC-MS/MS method employed was not capable of discerning L vs. D enantiomers of 2-HG. As such we assume herein that 2-HG from IDH2 is D-2-HG, while that from LDH or MDH2 is L-2-HG [1, 3, 4] .
Animals & primary cells
Male littermate wild type (WT) and Sirt3 -/-mice on a C57BL/6J background were used at 2 mo. of age. All mice were maintained in a pathogen-free vivarium with a 12 hr. For cellular hypoxia experiments, HEK293 cells were placed in a hypoxic chamber (pO 2 <0.1%) for 20 hr. as previously described [6] . Primary adult mouse cardiomyocytes were isolated as previously described [20] . Cytosolic pH was measured by fluorescent microscopy using the pH-sensitive probe BCECF as previously described [6] . To model ischemia, cardiomyocytes were plated on laminin-coated 25 mm glass cover slips (25,000 cells per slide) in 35 mm dishes, followed by over placement of a second cover slip to exclude oxygen and limit extracellular volume. We previously reported on a similar method using cartridges within the Seahorse XF apparatus to achieve similar ends [20, 21] . Cells in the center of the cover slip were imaged after 10 min.
Mitochondria were isolated from WT or Sirt3
-/-hearts as previously described [22] .
The activity of mitochondrial L-2-HG dehydrogenase was measured spectrophotometrically and by LC-MS/MS as previously described [6] .
Statistics
Significance between groups was determined by ANOVA, assuming a normal distribution, followed by post-hoc Student's t-test. Differences were considered statistically significant at p<0.05, and graphs show means ± standard errors.
RESULTS
We previously demonstrated a role for SIRT1 in the elevation of 2-HG observed in cardiac ischemic preconditioning (IPC) [14] . In addition, 2-HG is elevated in cells exposed to hypoxia [3, 4] . However, since these are distinct experimental systems (intermittent whole organ ischemia vs. prolonged cellular hypoxia), it is not clear if SIRT1 is also . CC-BY-NC 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/141416 doi: bioRxiv preprint first posted online May. 24, 2017; required for the latter phenomenon. To investigate this we measured 2-HG levels in HEK293 cells exposed to hypoxia with or without the SIRT1 inhibitor splitomicin (Sp). As expected, hypoxia markedly increased 2-HG levels ( Figure 1A ), and notably this effect was blunted by Sp, suggesting a similar role for SIRT1 in both hypoxic situations.
IDH2, MDH2 and LDH are enzymes capable of generating 2-HG [1, 3, 4, 6, 7] and are also thought to be targets for SIRT mediated deacetylation [15] [16] [17] 19, 23, 24] . Thus, we α -KG + NADPH as substrates, but neither generated substantial corresponding amounts of 2-HG. Instead, IDH2 is known to operate in reverse, using α -KG in a reductive carboxylation reaction to produce isocitrate [6, 26] . Together these data suggest that acetylation boosted the canonical activity of IDH2 (i.e., isocitrate α -KG), with no effect on its non-canonical activities (2-HG generation or reductive carboxylation). The fact that acetylation did impact IDH2 canonical activity suggests the lack of an effect on noncanonical activities (negative result) was not simply due to confounding experimental issues.
The mitochondrial enzyme MDH2 can also produce 2-HG [3, 4, 6, 7] , and notably lysine 239 of MDH2 is differentially acetylated in mice lacking the mitochondrial deacetylase SIRT3 [17] . Furthermore, an acetyl-mimetic K 239 Q mutant protein exhibits . CC-BY-NC 4.0 International license peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/141416 doi: bioRxiv preprint first posted online May. 24, 2017; lower MDH activity [17] , suggesting acetylation at this site is inhibitory. We acetylated purified MDH2 in-vitro [18] and verified this by western blot. As shown in Figure Figures 2G and 2H ). Overall, these data suggest that neither canonical nor alternative activities of MDH2 were impacted by acetylation.
Another enzyme implicated in 2-HG generation is LDH, and notably lysine 5 within LDH-A was identified as an acetylation site [27], with acetyl-mimetic mutation of this residue (K 5 Q) resulting in enzyme inhibition. In contrast to these mutant enzyme findings, when we acetylated purified LDH in-vitro ( Figure 3A) , we observed no effect on canonical activity (pyruvate + NADH lactate + NAD + ) ( Figures 3B and 3C ). Furthermore, 2-HG generation from α -KG by LDH was not affected by acetylation ( Figures 3D and 3E ).
Together these data suggest that acetylation does not impact the enzymatic properties of LDH.
To further investigate the possible role of lysine acetylation as a regulator of 2-HG generation, we examined mice with deletion of Sirt3 ( Figure 4A ), a mitochondrial SIRT known to deacetylate IDH2, MDH2 and LDH [15] [16] [17] 19, 23, 24] . As shown in Figures 4B and 4C, Sirt3 -/-hearts exhibited the expected hyper-acetylation of cardiac mitochondrial . CC-BY-NC 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/141416 doi: bioRxiv preprint first posted online May. 24, 2017; proteins (vs. wild-type, WT), but surprisingly this was accompanied by a 3.5-fold elevation Another potentially important regulator of 2-HG generation is acidic pH [6, 7] .
However, we did not observe any significant difference in pH between cardiomyocytes isolated from WT or Sirt3 -/-hearts ( Figures 4F and 4G) . Notably (and in agreement with previous studies), Sirt3 -/-hearts exhibited elevated NADH levels ( Figure 4C ), a phenomenon that has been attributed to inhibition of mitochondrial respiratory complex I (NADH ubiquinone oxidoreductase) [22, 29] and Figure 1A ), we measured the effects of Sp on ischemia-induced acidification of primary mouse cardiomyocytes. As shown in Figures 4H and 4J , Sp elicited a slight alkalinization alone and blunted the acidification caused by ischemia. These data suggest that the role of SIRT1 in the elevation of 2-HG in hypoxia/ischemia, is likely at a position upstream of acidification.
DISCUSSION & CONCLUSIONS
The conclusions of this study are as follows: (i) IDH2 (either naïve or acetylated) did not produce 2-HG; although Ac-IDH2 showed higher canonical activity (isocitrate α -KG); (ii) both canonical enzyme activities and 2-HG generation by Ac-MDH2 and Ac-LDH were similar to the corresponding naïve enzymes; (iii) 2-HG was elevated in Sirt3 -/-hearts, concurrent with higher NADH levels; and (iv) the ability of the SIRT1 inhibitor splitomicin to blunt 2-HG elevation in hypoxia/ischemia may be due to an upstream role for SIRT1 in regulating acidosis. Overall, these data suggest that direct acetylation of the major identified 2-HG generating enzymes is not a mechanism that regulates 2-HG.
Our observation that IDH2 acetylation by a physiologically relevant mechanism (acetyl-CoA) increases its canonical activity ( Figure 1C and 1D) is an interesting result.
Since acetyl-CoA is the upstream substrate for the Krebs cycle, it is possible that acetylCoA mediated IDH2 acetylation represents a novel feed-forward activation mechanism for the cycle. The importance of this relative to the already well-characterized regulation of this cycle by numerous allosteric mechanisms (e.g., Ca 2+ , NADH, phosphorylation) [31] [32] [33] remains to be seen.
A consistent finding in the current study was a sharp contrast with previous observations using acetyl-mimetic mutations in dehydrogenase enzymes [17, 25, 27 ].
Specifically, acetyl-mimetic K 413 Q of IDH2, K 239 Q of MDH2 and K 5 Q of LDH-A were all shown to result in lower activities for these enzymes. In contrast we found that acetylation stimulated IDH2 activity, while having no effect on MDH2 or LDH. The acetylation methods used herein were physiologically relevant [18] , and acetylation was verified by western blot, by mass spectrometry and by reversibility with a recombinant SIRT. Interpreting mutational studies can be problematic when mutations result in loss of function, and in the lysine acetylation field there are vanishingly few examples of acetyl-mimetic mutation .
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An important caveat in interpreting our findings, is subcellular compartmentation. In cardiomyocytes SIRT1 is cytosolic [15, 35] , and as shown in Figure 4 the SIRT1 inhibitor Sp results in alkalinization of the cardiomyocyte cytosol. Sp also blunts the hypoxic increase in 2-HG ( Figure 1A ). However, acetylation of cytosolic LDH does not impact 2-HG generation. Thus we conclude that SIRT1 may play a role in regulating 2-HG at a point upstream of acidification. In contrast, SIRT3 is mitochondrial and its genetic ablation has no effect on cytosolic pH, and no effect on L-2HGDH activity. Furthermore, no effect of acetylation on 2-HG generation was seen for the mitochondrial enzymes MDH2 or IDH2.
Thus, in the case of Sirt3
-/-, we speculate that elevated 2-HG originates at the level of reductive stress (excess NADH), possibly due to inhibition of mitochondrial complex I [22, 29] . Interestingly, the Sirt3 -/-mouse exhibits acetylation of cytosolic LDH [17] , and we showed that SIRT1 inhibition resulted in acetylation of numerous mitochondrial enzymes [15] . Thus, there appear to be signaling mechanisms by which inactivation (genetic or pharmacologic) of a SIRT in one cell compartment can impact acetylation in another compartment. Overall, regardless the compartment, it is clear from our results that direct regulation of acetylation of 2-HG generating enzymes by SIRT1 or SIRT3 does not impact 2-HG levels.
It was recently proposed that conversion of α -KG to 2-HG is a quantitatively significant mechanism by which "cells handle a mounting pool of reducing equivalents" 
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